Company news

Canntab Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CSE Bulletin: Delist - Canntab Therapeutics Limited (PILL)

June 14, 2024

Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

September 18, 2023

Canntab Announces Corporate Update

November 22, 2022

Canntab announces its entrance into the nova scotia Cannabis market

August 22, 2022

Canntab announces appointment of Richard Goldstein as interim CEO

August 2, 2022

Canntab Corporate Update

June 30, 2022

Canntab announces change of auditor

May 30, 2022

Canntab Engages Hamish Sutherland as Strategic Advisor

April 13, 2022

Canntab signs affiliate agrrement with OnPharm-United

March 23, 2022

Canntab signs historic agreement with First Nations growers GP inc. to address the opiate and illicit drug crisis affecting Indigenous Peoples throughout Canada

February 7, 2022

Canntab announces closing of convertible debenture private placement, warrant expiry extension and corporate update

February 1, 2022

Canntab officially launches its online E-Commerce platform

January 20, 2022

CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

January 10, 2022

Canntab enters into strategic partnership to provide alternatives to opiates through levitee clinics

December 16, 2021

Canntab Receives Medical Sales Licence from Health Canada

November 11, 2021

Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.

October 18, 2021

Canntab Announces the Early Exercise of $1,259,250 Warrants

June 3, 2021

Canntab Mourns the Loss of Co-Founder

May 25, 2021

Canntab Receives Export License Approval from Health Canada

March 30, 2021

Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

March 9, 2021

Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.

March 3, 2021

Canntab Engages Independent Trading Group for Market Making Services

February 17, 2021

Canntab Grants Options

February 3, 2021

Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets

February 1, 2021

Canntab Announces Closing of Convertible Debenture Private Placement

December 31, 2020

Canntab Begins Delivery of Tablets to MediPharm

December 1, 2020

Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

November 16, 2020

Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study

October 26, 2020

Canntab Announces Closing of Purchases of Cannabis Processing Equipment and Leasehold Improvements

October 19, 2020

Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets

September 21, 2020

Canntab announces planned purchases of cannabis processing equipment and leasehold improvements

August 21, 2020

Canntab Appoints Larry Latowsky as CEO

August 19, 2020

Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

June 2, 2020

Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer

May 15, 2020

Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference

May 11, 2020

Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

March 16, 2020

Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board

March 6, 2020

Canntab Announces Cancellation of Options and Issuance of Warrants

March 3, 2020

InvestmentPitch Media Video Discusses Canntab's Receipt of its Cannabis Standard Processing and Sales for Medical Purposes Licence from Health Canada and Close of 1st Tranche of Private Placement - Video Available on Investmentpitch.com

March 3, 2020

Canntab Receives Health Canada Licence and Closes $3.08M Offering

March 2, 2020

InvestmentPitch Media Video Discusses Canntab's Receipt of Cannabis Research Licence from Health Canada - Video Available on Investmentpitch.com

February 25, 2020

Canntab Awarded Health Canada Cannabis Research Licence

February 24, 2020

Canntab Announces Non-Brokered Private Placement

February 6, 2020

Canntab Submits Site Evidence Package to Health Canada to Obtain LP Status

December 23, 2019

Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

November 20, 2019

Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities

October 8, 2019

InvestmentPitch Media Video Discusses Canntab's Receipt of Initial Indication of Patentability for Immediate Release Cannabidiol Formulation - Video Available on Investmentpitch.com

August 16, 2019

Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation

August 15, 2019

InvestmentPitch Media Video Discusses Canntab's Update of Significant Developments Including Hemp Cultivation and Gel Capsule Manufacturing - Video Available on Investmentpitch.com

August 1, 2019

Canntab provides corporate update

July 31, 2019

Older news releases →

Decks

The 5 newest of 8 decks. Every deck is listed under its year.